These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35592852)

  • 1. Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes.
    Anaparti V; Wiens D; O'Neil LJ; Hubbard E; Robl R; Smolik I; Hitchon C; Lipsky PE; El-Gabalawy H
    Front Med (Lausanne); 2022; 9():823244. PubMed ID: 35592852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction.
    Kane D; Jensen LE; Grehan S; Whitehead AS; Bresnihan B; Fitzgerald O
    J Rheumatol; 2004 Jul; 31(7):1274-80. PubMed ID: 15229943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
    Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B
    Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis.
    Tuncer T; Kaya A; Gulkesen A; Kal GA; Kaman D; Akgol G
    Adv Clin Exp Med; 2019 May; 28(5):665-670. PubMed ID: 30740946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovium CD20 expression is a potential new predictor of bone erosion progression in very-early arthritis treated by sequential DMARDs monotherapy -- a pilot study from the VErA cohort.
    Lanfant-Weybel K; Michot C; Daveau R; Milliez PY; Auquit-Auckbur I; Fardellone P; Brazier M; Mejjad O; Daragon A; Krzanowska K; Jouen F; Tron F; Le Loarer F; Le Loët X; Vittecoq O
    Joint Bone Spine; 2012 Dec; 79(6):574-80. PubMed ID: 22459417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.
    Smeets TJ; Barg EC; Kraan MC; Smith MD; Breedveld FC; Tak PP
    Ann Rheum Dis; 2003 Jul; 62(7):635-8. PubMed ID: 12810425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.
    Smeets TJ; Dayer JM; Kraan MC; Versendaal J; Chicheportiche R; Breedveld FC; Tak PP
    Arthritis Rheum; 2000 Feb; 43(2):270-4. PubMed ID: 10693865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
    Pakozdi A; Amin MA; Haas CS; Martinez RJ; Haines GK; Santos LL; Morand EF; David JR; Koch AE
    Arthritis Res Ther; 2006; 8(4):R132. PubMed ID: 16872482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis.
    Cunnane G; FitzGerald O; Hummel KM; Youssef PP; Gay RE; Gay S; Bresnihan B
    Arthritis Rheum; 2001 Aug; 44(8):1744-53. PubMed ID: 11508424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paired Rheumatoid Arthritis Synovial Biopsies From Small and Large Joints Show Similar Global Transcriptomic Patterns With Enrichment of Private Specificity
    Triaille C; Vansteenkiste L; Constant M; Ambroise J; Méric de Bellefon L; Nzeusseu Toukap A; Sokolova T; Galant C; Coulie P; Carrasco J; Durez P; Lauwerys BR
    Front Immunol; 2020; 11():593083. PubMed ID: 33329580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial IL-21/TNF-producing CD4
    Lebre MC; Vieira PL; Tang MW; Aarrass S; Helder B; Newsom-Davis T; Tak PP; Screaton GR
    J Leukoc Biol; 2017 Mar; 101(3):775-783. PubMed ID: 27733582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.
    O'Hara R; Murphy EP; Whitehead AS; FitzGerald O; Bresnihan B
    Arthritis Rheum; 2004 Jun; 50(6):1788-99. PubMed ID: 15188355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased baseline RUNX2, caspase 3 and p21 gene expressions in the peripheral blood of disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients are associated with improved clinical response to methotrexate therapy.
    Tchetina EV; Demidova NV; Markova GA; Taskina EA; Glukhova SI; Karateev DE
    Int J Rheum Dis; 2017 Oct; 20(10):1468-1480. PubMed ID: 28741869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.
    Humby F; Lewis M; Ramamoorthi N; Hackney JA; Barnes MR; Bombardieri M; Setiadi AF; Kelly S; Bene F; DiCicco M; Riahi S; Rocher V; Ng N; Lazarou I; Hands R; van der Heijde D; Landewé RBM; van der Helm-van Mil A; Cauli A; McInnes I; Buckley CD; Choy EH; Taylor PC; Townsend MJ; Pitzalis C
    Ann Rheum Dis; 2019 Jun; 78(6):761-772. PubMed ID: 30878974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-quantitative analysis of
    Ravikanth R; Singh JK
    World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis.
    Badot V; Galant C; Nzeusseu Toukap A; Theate I; Maudoux AL; Van den Eynde BJ; Durez P; Houssiau FA; Lauwerys BR
    Arthritis Res Ther; 2009; 11(2):R57. PubMed ID: 19389237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.